ProfileGDS4718 / 213438_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 19% 33% 62% 24% 26% 16% 15% 23% 27% 26% 23% 36% 22% 17% 18% 48% 33% 19% 27% 69% 25% 30% 22% 35% 29% 20% 43% 14% 29% 20% 17% 46% 32% 27% 26% 25% 17% 34% 32% 84% 28% 18% 29% 22% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1248219
GSM549102patient 115, normal, homogenized [OPG study]4.6671933
GSM549104patient 119, normal, homogenized [OPG study]6.3045662
GSM549108patient 138, normal, homogenized [OPG study]4.3207824
GSM549119patient 077, normal, homogenized [OPG study]4.3883426
GSM549133patient 032, cancer, homogenized [OPG study]3.9643516
GSM549139patient 042, cancer, homogenized [OPG study]3.9526815
GSM549099patient 107, normal, homogenized [OPG study]4.2722423
GSM549109patient 139, normal, homogenized [OPG study]4.431527
GSM549110patient 046, normal, homogenized [OPG study]4.4014226
GSM549114patient 063, normal, homogenized [OPG study]4.2339223
GSM549122patient 082, normal, homogenized [OPG study]4.8043236
GSM549134patient 033, cancer, homogenized [OPG study]4.1988322
GSM549136patient 036, cancer, homogenized [OPG study]3.9715817
GSM549140patient 044, cancer, homogenized [OPG study]4.0401418
GSM549111patient 047, normal, homogenized [OPG study]5.393448
GSM549113patient 057, normal, homogenized [OPG study]4.613133
GSM549132patient 031, cancer, homogenized [OPG study]4.1074519
GSM549137patient 038, cancer, homogenized [OPG study]4.4105327
GSM549142patient 047, cancer, homogenized [OPG study]6.783269
GSM549100patient 110, normal, homogenized [OPG study]4.3512525
GSM549107patient 135, normal, homogenized [OPG study]4.5152530
GSM549115patient 068, normal, homogenized [OPG study]4.1666922
GSM549116patient 072, normal, homogenized [OPG study]4.7285735
GSM549120patient 078, normal, homogenized [OPG study]4.5062129
GSM549131patient 030, cancer, homogenized [OPG study]4.0824920
GSM549118patient 074, normal, homogenized [OPG study]5.1501543
GSM549129patient 027, cancer, homogenized [OPG study]3.9209714
GSM549123patient 088, normal, homogenized [OPG study]4.4877229
GSM549124patient 006, cancer, homogenized [OPG study]4.1946320
GSM549126patient 015, cancer, homogenized [OPG study]4.0345917
GSM549128patient 025, cancer, homogenized [OPG study]5.2875746
GSM549103patient 117, normal, homogenized [OPG study]4.6894432
GSM549117patient 073, normal, homogenized [OPG study]4.3722427
GSM549138patient 041, cancer, homogenized [OPG study]4.3646426
GSM549141patient 045, cancer, homogenized [OPG study]4.2890125
GSM549130patient 028, cancer, homogenized [OPG study]4.0287917
GSM549101patient 111, normal, homogenized [OPG study]4.7308134
GSM549105patient 128, normal, homogenized [OPG study]4.6352832
GSM549106patient 134, normal, homogenized [OPG study]8.5630684
GSM549112patient 048, normal, homogenized [OPG study]4.4634328
GSM549125patient 011, cancer, homogenized [OPG study]4.097118
GSM549127patient 024, cancer, homogenized [OPG study]4.4917929
GSM549135patient 035, cancer, homogenized [OPG study]4.1891622